Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2022

Open Access 01-12-2022 | Obesity | Research

Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis

Authors: Junjie Huang, Wing Sze Pang, Veeleah Lok, Lin Zhang, Don Eliseo Lucero-Prisno III, Wanghong Xu, Zhi-Jie Zheng, Edmar Elcarte, Mellissa Withers, Martin C. S. Wong, NCD Global Health Research Group, Association of Pacific Rim Universities (APRU)

Published in: Journal of Hematology & Oncology | Issue 1/2022

Login to get access

Abstract

Background

Hodgkin lymphoma is a lymphatic malignancy commonly found in cervical lymph nodes. This study evaluated the worldwide incidence, mortality, associated risk factors, and temporal trends of Hodgkin lymphoma by sex, age, and country.

Methods

The age-standardised Hodgkin lymphoma incidence and mortality were retrieved from the GLOBOCAN, CI5 volumes I-XI, WHO mortality database, the NORDCAN and SEER Program. The age-standardised prevalence of smoking, alcohol drinking, obesity, and hypertension was also extracted for each country. Trends were tested using Average Annual Percentage Change (AAPC) from Joinpoint regression analysis.

Results

The Hodgkin lymphoma incidence and mortality were 0.98 and 0.26 per 100,000 in 2020. A higher incidence was observed in high-income countries, while higher mortality was found in low-income countries. Incidence and mortality were associated with GDP per capita, prevalence of smoking, obesity, and hypertension at the population level. Despite the decreasing mortality trend, there was an increasing incidence, especially among females, younger population, and subjects from Asian countries.

Conclusions

There was an increasing trend in Hodgkin lymphoma incidence, especially among subjects who were female, younger population, and from Asian countries. Further studies are needed to investigate the reasons for these epidemiologic trends.
Appendix
Available only for authorised users
Literature
14.
go back to reference Bray FCMML, Piñeros M, Znaor A, Zanetti R, Ferlay J, editors. Cancer incidence in five continents, Vol. XI (electronic version) Lyon: International Agency for Research on Cancer. 2017. Accessed 4 Feb 2022. https://ci5.iarc.fr. Bray FCMML, Piñeros M, Znaor A, Zanetti R, Ferlay J, editors. Cancer incidence in five continents, Vol. XI (electronic version) Lyon: International Agency for Research on Cancer. 2017. Accessed 4 Feb 2022. https://​ci5.​iarc.​fr.
Metadata
Title
Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis
Authors
Junjie Huang
Wing Sze Pang
Veeleah Lok
Lin Zhang
Don Eliseo Lucero-Prisno III
Wanghong Xu
Zhi-Jie Zheng
Edmar Elcarte
Mellissa Withers
Martin C. S. Wong
NCD Global Health Research Group, Association of Pacific Rim Universities (APRU)
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2022
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/s13045-022-01281-9

Other articles of this Issue 1/2022

Journal of Hematology & Oncology 1/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine